Literature DB >> 7149109

A case of encephalitis in a human associated with a serologic rise to Jamestown Canyon virus.

P R Grimstad, C L Shabino, C H Calisher, R J Waldman.   

Abstract

An 8-year-old girl living in rural southwestern Michigan experienced sudden onset of symptoms beginning with headache, dizziness and fever which rapidly progressed to central nervous system involvement with seizures and coma. Following 27 days of hospitalization her recovery was uneventful, with no apparent sequelae 15 months after discharge. Serologic studies of paired sera showed a rise in antibody to Jamestown Canyon virus, a member of the California serogroup (family Bunyaviridae). Specific IgM anti-Jamestown Canyon virus antibody was detected in sera drawn 9 days after onset. A concomitant rise in complement fixation antibody to herpesvirus was also noted. We believe this is the first reported case of encephalitis associated with Jamestown Canyon virus infection. Reasons are presented for the current inability to routinely detect infection and clinical illness caused by this virus.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7149109     DOI: 10.4269/ajtmh.1982.31.1238

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  12 in total

1.  Jamestown Canyon Virus Disease in the United States-2000-2013.

Authors:  Daniel M Pastula; Diep K Hoang Johnson; Jennifer L White; Alan P Dupuis; Marc Fischer; J Erin Staples
Journal:  Am J Trop Med Hyg       Date:  2015-06-01       Impact factor: 2.345

2.  La Crosse virus nonstructural protein NSs counteracts the effects of short interfering RNA.

Authors:  Samantha S Soldan; Matthew L Plassmeyer; Meghan K Matukonis; Francisco González-Scarano
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Laboratory Validation of a Real-Time RT-PCR Assay for the Detection of Jamestown Canyon Virus.

Authors:  Holly R Hughes; Joan L Kenney; Brandy J Russell; Amy J Lambert
Journal:  Pathogens       Date:  2022-05-03

4.  Production and use of a hemagglutinin for detecting antibody to Jamestown Canyon virus.

Authors:  P R Grimstad; H Artsob; N Karabatsos; C H Calisher
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

5.  RNA binding domain of Jamestown Canyon virus S segment RNAs.

Authors:  Monica M Ogg; Jean L Patterson
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

6.  Acute Human Inkoo and Chatanga Virus Infections, Finland.

Authors:  Niina Putkuri; Anu Kantele; Lev Levanov; Ilkka Kivistö; Markus Brummer-Korvenkontio; Antti Vaheri; Olli Vapalahti
Journal:  Emerg Infect Dis       Date:  2016-05       Impact factor: 6.883

7.  High Seroprevalence of Jamestown Canyon Virus among Deer and Humans, Nova Scotia, Canada.

Authors:  Glenn Patriquin; Michael Drebot; Teri Cole; Robbin Lindsay; Emily Schleihauf; B Lynn Johnston; Kristina Dimitrova; Maya Traykova-Andonova; Angela Mask; David Haldane; Todd F Hatchette
Journal:  Emerg Infect Dis       Date:  2018-01       Impact factor: 6.883

8.  Enhanced Arboviral Surveillance to Increase Detection of Jamestown Canyon Virus Infections, Wisconsin, 2011-2016.

Authors:  Eduard Matkovic; Diep K Hoang Johnson; J Erin Staples; Maria C Mora-Pinzon; Lina I Elbadawi; Rebecca A Osborn; David M Warshauer; Mark V Wegner; Jeffrey P Davis
Journal:  Am J Trop Med Hyg       Date:  2019-02       Impact factor: 2.345

9.  Jamestown Canyon virus in Massachusetts: clinical case series and vector screening.

Authors:  Cormac M Kinsella; Molly L Paras; Sandra Smole; Samar Mehta; Vijay Ganesh; Lin H Chen; Daniel P McQuillen; Ruta Shah; Justin Chan; Matthew Osborne; Scott Hennigan; Frederic Halpern-Smith; Catherine M Brown; Pardis Sabeti; Anne Piantadosi
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

Review 10.  Throw out the Map: Neuropathogenesis of the Globally Expanding California Serogroup of Orthobunyaviruses.

Authors:  Alyssa B Evans; Karin E Peterson
Journal:  Viruses       Date:  2019-08-29       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.